Literature DB >> 24836575

Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage.

Lukas Schwab1, Luise Goroncy2, Senthilnathan Palaniyandi3, Sanjivan Gautam4, Antigoni Triantafyllopoulou5, Attila Mocsai6, Wilfried Reichardt7, Fridrik J Karlsson8, Sabarinath V Radhakrishnan9, Kathrin Hanke10, Annette Schmitt-Graeff11, Marina Freudenberg12, Friederike D von Loewenich13, Philipp Wolf14, Franziska Leonhardt10, Nicoleta Baxan7, Dietmar Pfeifer15, Oliver Schmah15, Anne Schönle15, Stefan F Martin16, Roland Mertelsmann15, Justus Duyster15, Jürgen Finke15, Marco Prinz17, Philipp Henneke18, Hans Häcker19, Gerhard C Hildebrandt3, Georg Häcker20, Robert Zeiser21.   

Abstract

Acute graft-versus-host disease (GVHD) considerably limits wider usage of allogeneic hematopoietic cell transplantation (allo-HCT). Antigen-presenting cells and T cells are populations customarily associated with GVHD pathogenesis. Of note, neutrophils are the largest human white blood cell population. The cells cleave chemokines and produce reactive oxygen species, thereby promoting T cell activation. Therefore, during an allogeneic immune response, neutrophils could amplify tissue damage caused by conditioning regimens. We analyzed neutrophil infiltration of the mouse ileum after allo-HCT by in vivo myeloperoxidase imaging and found that infiltration levels were dependent on the local microbial flora and were not detectable under germ-free conditions. Physical or genetic depletion of neutrophils reduced GVHD-related mortality. The contribution of neutrophils to GVHD severity required reactive oxygen species (ROS) because selective Cybb (encoding cytochrome b-245, beta polypeptide, also known as NOX2) deficiency in neutrophils impairing ROS production led to lower levels of tissue damage, GVHD-related mortality and effector phenotype T cells. Enhanced survival of Bcl-xL transgenic neutrophils increased GVHD severity. In contrast, when we transferred neutrophils lacking Toll-like receptor-2 (TLR2), TLR3, TLR4, TLR7 and TLR9, which are normally less strongly activated by translocating bacteria, into wild-type C57BL/6 mice, GVHD severity was reduced. In humans, severity of intestinal GVHD strongly correlated with levels of neutrophils present in GVHD lesions. This study describes a new potential role for neutrophils in the pathogenesis of GVHD in both mice and humans.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24836575     DOI: 10.1038/nm.3517

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  43 in total

1.  Potential role of the NADPH oxidase NOX1 in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.

Authors:  Masashi Yasuda; Shinichi Kato; Naoki Yamanaka; Maho Iimori; Daichi Utsumi; Yumeno Kitahara; Kazumi Iwata; Kuniharu Matsuno; Kikuko Amagase; Chihiro Yabe-Nishimura; Koji Takeuchi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

2.  Spleen tyrosine kinase (Syk) is a potent target for GvHD prevention at different cellular levels.

Authors:  F Leonhardt; K Zirlik; M Buchner; G Prinz; A-K Hechinger; U V Gerlach; P Fisch; A Schmitt-Gräff; W Reichardt; R Zeiser
Journal:  Leukemia       Date:  2012-01-17       Impact factor: 11.528

3.  Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantation.

Authors:  Wilfried Reichardt; Christoph Dürr; Dominik von Elverfeldt; Eva Jüttner; Ulrike V Gerlach; Mayumi Yamada; Benjie Smith; Robert S Negrin; Robert Zeiser
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

4.  SMAD3 prevents graft-versus-host disease by restraining Th1 differentiation and granulocyte-mediated tissue damage.

Authors:  Martin Giroux; Jean-Sébastien Delisle; Simon-David Gauthier; Krista M Heinonen; Julie Hinsinger; Billy Houde; Louis Gaboury; Sylvie Brochu; Jiangping Wu; Marie-Josée Hébert; Claude Perreault
Journal:  Blood       Date:  2010-11-30       Impact factor: 22.113

5.  Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R.

Authors:  Konrad Wilhelm; Jayanthi Ganesan; Tobias Müller; Christoph Dürr; Melanie Grimm; Andreas Beilhack; Christine D Krempl; Stephan Sorichter; Ulrike V Gerlach; Eva Jüttner; Alf Zerweck; Frank Gärtner; Patrizia Pellegatti; Francesco Di Virgilio; Davide Ferrari; Neeraja Kambham; Paul Fisch; Jürgen Finke; Marco Idzko; Robert Zeiser
Journal:  Nat Med       Date:  2010-11-21       Impact factor: 53.440

6.  Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer.

Authors:  Philipp Wolf; Nikolaus Freudenberg; Patrick Bühler; Karen Alt; Wolfgang Schultze-Seemann; Ulrich Wetterauer; Ursula Elsässer-Beile
Journal:  Prostate       Date:  2010-04-01       Impact factor: 4.104

7.  Chemical mechanism of the Gram stain and synthesis of a new electron-opaque marker for electron microscopy which replaces the iodine mordant of the stain.

Authors:  J A Davies; G K Anderson; T J Beveridge; H C Clark
Journal:  J Bacteriol       Date:  1983-11       Impact factor: 3.490

8.  Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease.

Authors:  K R Cooke; G R Hill; J M Crawford; D Bungard; Y S Brinson; J Delmonte; J L Ferrara
Journal:  J Clin Invest       Date:  1998-11-15       Impact factor: 14.808

9.  Bioluminescence imaging of myeloperoxidase activity in vivo.

Authors:  Shimon Gross; Seth T Gammon; Britney L Moss; Daniel Rauch; John Harding; Jay W Heinecke; Lee Ratner; David Piwnica-Worms
Journal:  Nat Med       Date:  2009-03-22       Impact factor: 53.440

10.  The Nlrp3 inflammasome regulates acute graft-versus-host disease.

Authors:  Dragana Jankovic; Jayanthi Ganesan; Michael Bscheider; Natalie Stickel; Felix C Weber; Greta Guarda; Marie Follo; Dietmar Pfeifer; Aubry Tardivel; Kristina Ludigs; Abdellatif Bouazzaoui; Katrin Kerl; Julius C Fischer; Tobias Haas; Annette Schmitt-Gräff; Anand Manoharan; Leonard Müller; Jürgen Finke; Stefan F Martin; Oliver Gorka; Christian Peschel; Jürgen Ruland; Marco Idzko; Justus Duyster; Ernst Holler; Lars E French; Hendrik Poeck; Emmanuel Contassot; Robert Zeiser
Journal:  J Exp Med       Date:  2013-08-26       Impact factor: 14.307

View more
  97 in total

1.  Neutrophil extracellular traps (NETs) contribute to pathological changes of ocular graft-vs.-host disease (oGVHD) dry eye: Implications for novel biomarkers and therapeutic strategies.

Authors:  Seungwon An; Ilangovan Raju; Bayasgalan Surenkhuu; Ji-Eun Kwon; Shilpa Gulati; Muge Karaman; Anubhav Pradeep; Satyabrata Sinha; Christine Mun; Sandeep Jain
Journal:  Ocul Surf       Date:  2019-04-06       Impact factor: 5.033

Review 2.  Microbiome-intestine cross talk during acute graft-versus-host disease.

Authors:  Hind Rafei; Robert R Jenq
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

Review 3.  Immunopathology and biology-based treatment of steroid-refractory graft-versus-host disease.

Authors:  Tomomi Toubai; John Magenau
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

Review 4.  Biology-driven developments in the therapy of acute graft-versus-host disease.

Authors:  Robert Zeiser
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

5.  Donor interleukin-22 and host type I interferon signaling pathway participate in intestinal graft-versus-host disease via STAT1 activation and CXCL10.

Authors:  B Lamarthée; F Malard; C Gamonet; C Bossard; M Couturier; J-C Renauld; M Mohty; P Saas; B Gaugler
Journal:  Mucosal Immunol       Date:  2015-07-08       Impact factor: 7.313

Review 6.  Microbiota—implications for immunity and transplantation.

Authors:  Jonathan S Bromberg; W Florian Fricke; C Colin Brinkman; Thomas Simon; Emmanuel F Mongodin
Journal:  Nat Rev Nephrol       Date:  2015-05-12       Impact factor: 28.314

Review 7.  The microbiome and innate immunity.

Authors:  Christoph A Thaiss; Niv Zmora; Maayan Levy; Eran Elinav
Journal:  Nature       Date:  2016-07-07       Impact factor: 49.962

8.  Dynamics of M1 macrophages in oral mucosal lesions during the development of acute graft-versus-host disease in rats.

Authors:  K Seno; M Yasunaga; H Kajiya; K Izaki-Hagio; H Morita; M Yoneda; T Hirofuji; J Ohno
Journal:  Clin Exp Immunol       Date:  2017-09-28       Impact factor: 4.330

9.  Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice.

Authors:  Marcel R M van den Brink; Robert R Jenq; Yusuke Shono; Melissa D Docampo; Jonathan U Peled; Suelen M Perobelli; Enrico Velardi; Jennifer J Tsai; Ann E Slingerland; Odette M Smith; Lauren F Young; Jyotsna Gupta; Sophia R Lieberman; Hillary V Jay; Katya F Ahr; Kori A Porosnicu Rodriguez; Ke Xu; Marco Calarfiore; Hendrik Poeck; Silvia Caballero; Sean M Devlin; Franck Rapaport; Jarrod A Dudakov; Alan M Hanash; Boglarka Gyurkocza; George F Murphy; Camilla Gomes; Chen Liu; Eli L Moss; Shannon B Falconer; Ami S Bhatt; Ying Taur; Eric G Pamer
Journal:  Sci Transl Med       Date:  2016-05-18       Impact factor: 17.956

10.  Ruxolitinib-ECP combination treatment for refractory severe chronic graft-versus-host disease.

Authors:  Kristina Maas-Bauer; Chrissoula Kiote-Schmidt; Hartmut Bertz; Petya Apostolova; Ralph Wäsch; Gabriele Ihorst; Jürgen Finke; Robert Zeiser
Journal:  Bone Marrow Transplant       Date:  2020-11-17       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.